Sep. 01, 2022
Daniel Wiegand on the RNA Revolution
We’re in the midst of an RNA revolution, and Daniel Wiegand and his team are prepared to deliver RNA to the world by making high-quality RNA oligonucleotides cheaper and more easily accessible. After an impactful co-op experience at a pharmaceutical company during his undergraduate years, Daniel understood what it truly meant to be a scientist, and he was hooked. His passion for cutting-edge, impactful science brought him to the Wyss, where he is leading the development of a manufacturing platform for the enzymatic synthesis of RNA oligonucleotides for use in therapeutics. Learn more about Daniel and his work in this month’s Humans of the Wyss.